These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32520696)

  • 1. Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain.
    Buigues C; Queralt A; De Velasco JA; Salvador-Sanz A; Jennings C; Wood D; Trapero I
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1412-1418. PubMed ID: 32520696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse-led and Interdisciplinary Secondary Cardiovascular Prevention Programmes: Spanish Cohort of the EUROACTION Project.
    Buigues C; Trapero I; Velasco JA; Salvador-Sanz A; Jennings C; Wood D; Queralt A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(13):1319-1329. PubMed ID: 35362378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.
    Wood DA; Kotseva K; Connolly S; Jennings C; Mead A; Jones J; Holden A; De Bacquer D; Collier T; De Backer G; Faergeman O;
    Lancet; 2008 Jun; 371(9629):1999-2012. PubMed ID: 18555911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of evidence-based guidelines in preventive cardiology: the EUROACTION program.
    Pearson TA;
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):8-9. PubMed ID: 18941437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.
    Nieuwkerk PT; Nierman MC; Vissers MN; Locadia M; Greggers-Peusch P; Knape LP; Kastelein JJ; Sprangers MA; de Haes HC; Stroes ES
    Am J Cardiol; 2012 Sep; 110(5):666-72. PubMed ID: 22621795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
    Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.
    Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Castro Conde A; Cifkova R; Crowley J; Davletov K; Deckers J; De Smedt D; De Sutter J; Dilic M; Dolzhenko M; Dzerve V; Erglis A; Fras Z; Gaita D; Gotcheva N; Heuschmann P; Hasan-Ali H; Jankowski P; Lalic N; Lehto S; Lovic D; Mancas S; Mellbin L; Milicic D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Z; Stöerk S; Tokgözoğlu L; Tsioufis C; Vulic D; Wood D;
    Eur J Prev Cardiol; 2019 May; 26(8):824-835. PubMed ID: 30739508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers.
    Malo S; Aguilar-Palacio I; Feja C; Menditto E; Lallana MJ; Andrade E; Casasnovas JA; Rabanaque MJ
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):26-32. PubMed ID: 28473266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
    Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
    Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.
    Jennings C; Kotseva K; De Bacquer D; Hoes A; de Velasco J; Brusaferro S; Mead A; Jones J; Tonstad S; Wood D;
    Eur Heart J; 2014 Jun; 35(21):1411-20. PubMed ID: 24616337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia: Experience in the Lipid Clinic of Alava.
    Pérez García L
    Clin Investig Arterioscler; 2018; 30(5):224-229. PubMed ID: 29980385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.